Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
SHC1	6464	broad.mit.edu	37	1	154940985	154940985	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr1:154940985C>T	ENST00000448116.2	-	4	956	c.736G>A	c.(736-738)Gca>Aca	p.A246T	SHC1_ENST00000490667.1_5'Flank|SHC1_ENST00000368450.1_Missense_Mutation_p.A136T|SHC1_ENST00000368449.4_Missense_Mutation_p.A17T|SHC1_ENST00000606391.1_Missense_Mutation_p.A47T|SHC1_ENST00000368453.4_Missense_Mutation_p.A136T|SHC1_ENST00000368445.5_Missense_Mutation_p.A246T	NM_001130040.1	NP_001123512.1	P29353	SHC1_HUMAN	SHC (Src homology 2 domain containing) transforming protein 1	246	PID.	NA			activation of MAPK activity|blood coagulation|epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|positive regulation of DNA replication|Ras protein signal transduction|regulation of epidermal growth factor receptor activity|regulation of growth	cytosol|mitochondrial matrix|Shc-EGFR complex	epidermal growth factor receptor binding|insulin receptor binding|insulin-like growth factor receptor binding|phospholipid binding|protein binding|transmembrane receptor protein tyrosine kinase adaptor activity			breast(1)|endometrium(5)|kidney(2)|large_intestine(2)|lung(8)|prostate(1)|skin(1)	20	all_epithelial(22;4.9e-30)|all_lung(78;4.1e-28)|all_hematologic(923;0.0359)|Hepatocellular(266;0.0877)|all_neural(408;0.245)		BRCA - Breast invasive adenocarcinoma(34;0.00034)			TTGCAGTCTGCGGCCATGAGG	0.552		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NSCLC(4;32 234 1864 2492 3259 13747 17376)					NA		NA				0			NA	NA	NA	NA	NA	C	THR/ALA,THR/ALA,THR/ALA,THR/ALA,THR/ALA	0,4406	NA	0,0,2203	192	202	199	NA	736,406,271,406,736	5.4	1	1	NA	199	1,8599	1.2+/-3.3	0,1,4299	no	missense,missense,missense,missense,missense	SHC1	NM_001130040.1,NM_001130041.1,NM_001202859.1,NM_003029.4,NM_183001.4	58,58,58,58,58	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	benign,benign,benign,benign,benign	246/585,136/474,91/429,136/475,246/584	154940985	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000160691	HGNC:10840	NM_183001	Approved	uc001ffw.3	NA	B5BU19|D3DV78|O15290|Q5T180|Q5T183|Q5T184|Q5T185|Q5T186|Q8N4K5|Q96CL1	ENST00000448116.2	37	CCDS44233.1	.	.	.	.	.	.	.	.	.	.	C	15.42	2.827512	0.50845	0.0	1.16E-4	ENSG00000160691	ENST00000368445;ENST00000448116;ENST00000368449;ENST00000368453;ENST00000368450;ENST00000368443;ENST00000414115;ENST00000444179;ENST00000412170;ENST00000366442	T;T;T;T;T;T;T;T;T	0.32272	2.07;2.07;2.07;2.07;2.07;1.46;2.07;2.07;2.07	5.45	5.45	0.79879	Phosphotyrosine interaction domain (3);Pleckstrin homology-type (1);	0.124032	0.53938	D	0.000045	T	0.07143	0.0181	N	0.11000	0.08	0.33533	D	0.593833	B;B;B	0.32829	0.386;0.023;0.029	B;B;B	0.29524	0.103;0.009;0.016	T	0.19031	-1.0318	10	0.23891	T	0.37	.	12.4188	0.55508	0.283:0.717:0.0:0.0	.	25;246;246	Q59HB0;P29353-6;P29353	.;.;SHC1_HUMAN	T	246;246;47;136;136;182;17;17;136;136	ENSP00000357430:A246T;ENSP00000401303:A246T;ENSP00000357434:A47T;ENSP00000357438:A136T;ENSP00000357435:A136T;ENSP00000404908:A17T;ENSP00000398864:A17T;ENSP00000398441:A136T;ENSP00000396162:A136T	ENSP00000396162:A136T	A	-	1	0	SHC1	153207609	0.998000	0.40836	1.000000	0.80357	0.993000	0.82548	0.811000	0.27198	2.555000	0.86185	0.467000	0.42956	GCA	SHC1-002	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000090779.2	-122.939573	KEEP		-	7.665569	0.010549	5	469	---	---	---	---	1	0.9347741	2	416	0	356	6	515	0	356	2	0	0	0	0	0	356	6	515	0	356	2	TP
PGBD2	0	broad.mit.edu	37	1	249211398	249211398	+	Silent	SNP	C	C	A			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr1:249211398C>A	ENST00000539153.1	+	4	861	c.606C>A	c.(604-606)ccC>ccA	p.P202P	PGBD2_ENST00000462488.1_Intron|PGBD2_ENST00000329291.5_Silent_p.P205P|PGBD2_ENST00000355360.4_Intron			Q6P3X8	PGBD2_HUMAN	piggyBac transposable element derived 2	205		NA						p.P205P(1)		NS(1)|endometrium(3)|lung(6)|ovary(1)|skin(3)	14	all_cancers(71;3.33e-06)|all_epithelial(71;2.41e-06)|Breast(184;0.00909)|Ovarian(71;0.0377)|all_lung(81;0.0458)|Lung NSC(105;0.0494)|Melanoma(84;0.199)	all_cancers(173;0.012)	OV - Ovarian serous cystadenocarcinoma(106;0.00989)			AAACCTCTCCCGATTCACATC	0.398		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				1	Substitution - coding silent(1)	lung(1)	NA	NA	NA	NA	NA				NA		137	140	139	NA		NA	NA	1	NA	NA											NA				249211398		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000185220	HGNC:19399		Approved	uc001ifh.3	NA	B3KVR8|Q6MZF8	ENST00000539153.1	37																																																																																				PGBD2-201	KNOWN	basic	protein_coding	NA	protein_coding		-47.089302	KEEP		+	6.665212	0.019324	4	203	---	---	---	---	1	0.1358137	6	22	0	151	4	217	0	151	2	0	0	0	0	0	151	4	217	0	151	2	TP
PLA2R1	0	broad.mit.edu	37	2	160869870	160869870	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr2:160869870C>A	ENST00000283243.7	-	10	1774	c.1568G>T	c.(1567-1569)gGt>gTt	p.G523V	PLA2R1_ENST00000392771.1_Missense_Mutation_p.G523V	NM_001195641.1|NM_007366.4	NP_001182570.1|NP_031392.3	Q13018	PLA2R_HUMAN	phospholipase A2 receptor 1, 180kDa	523	C-type lectin 3.	NA		RHG -> ETC (in Ref. 1; AAA70110/ AAC50163).	endocytosis	extracellular space|integral to plasma membrane	receptor activity|sugar binding		PLA2R1/RBMS1(2)	central_nervous_system(1)|endometrium(8)|kidney(2)|large_intestine(17)|lung(20)|ovary(1)|pancreas(1)|prostate(1)|skin(7)|stomach(1)|upper_aerodigestive_tract(1)	60						ACAGAATCCACCATGTCTCTC	0.378		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA				NA		100	95	97	NA		NA	NA	2	NA	NA											NA				160869870		2203	4300	6503	SO:0001583	missense			ENSG00000153246	HGNC:9042		Approved	uc002ube.2	NA	B2RTU9|D3DPB1|Q13019|Q15095|Q53R45|Q53RR7	ENST00000283243.7	37	CCDS33309.1	.	.	.	.	.	.	.	.	.	.	C	19.84	3.901105	0.72754	.	.	ENSG00000153246	ENST00000283243;ENST00000392771	T;T	0.10005	2.92;2.92	5.26	4.39	0.52855	C-type lectin fold (1);C-type lectin-like (1);C-type lectin (2);	0.236182	0.43416	D	0.000574	T	0.35682	0.0940	M	0.87038	2.855	0.80722	D	1	P;D;D	0.76494	0.834;0.993;0.999	B;P;D	0.64776	0.365;0.903;0.929	T	0.39961	-0.9588	10	0.72032	D	0.01	.	13.9664	0.64211	0.0:0.9266:0.0:0.0734	.	523;523;523	B7ZML4;Q13018-2;Q13018	.;.;PLA2R_HUMAN	V	523	ENSP00000283243:G523V;ENSP00000376524:G523V	ENSP00000283243:G523V	G	-	2	0	PLA2R1	160578116	0.995000	0.38212	0.844000	0.33320	0.966000	0.64601	3.718000	0.54919	1.344000	0.45657	0.650000	0.86243	GGT	PLA2R1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000333820.1	44.572144	KEEP		-	47.35876	0.271186	16	43	---	---	---	---	1	0.9407691	9	7	0	43	16	47	0	43	2	0	0	0	0	0	43	16	47	0	43	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).		activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA				NA		112	104	107	NA		NA	NA	7	NA	NA											NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	69.491398	KEEP		-	73.042156	0.280488	23	59	---	---	---	---	1	0.9922336	13	12	0	105	25	69	0	105	2	1	1	435	622	0	105	25	69	0	105	2	TP
CSRNP2	81566	broad.mit.edu	37	12	51467752	51467752	+	Missense_Mutation	SNP	C	C	G			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr12:51467752C>G	ENST00000228515.1	-	3	562	c.265G>C	c.(265-267)Ggt>Cgt	p.G89R	CSRNP2_ENST00000550461.1_5'Flank	NM_030809.2	NP_110436.1	Q9H175	CSRN2_HUMAN	cysteine-serine-rich nuclear protein 2	89		NA			apoptosis|positive regulation of transcription from RNA polymerase II promoter	nucleus	DNA binding|sequence-specific DNA binding transcription factor activity			central_nervous_system(1)|cervix(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(5)|urinary_tract(1)	14						GAGCTACCACCCTGGCTGGGC	0.552		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA				NA		85	90	88	NA		NA	NA	12	NA	NA											NA				51467752		2203	4300	6503	SO:0001583	missense				HGNC:16006		Approved	uc001rxu.2	NA		ENST00000228515.1	37	CCDS8807.1	.	.	.	.	.	.	.	.	.	.	C	31	5.099299	0.94197	.	.	ENSG00000110925	ENST00000228515;ENST00000548981	T;T	0.15834	2.39;2.39	5.11	5.11	0.69529	.	0.000000	0.85682	D	0.000000	T	0.50257	0.1605	M	0.89414	3.03	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	T	0.57837	-0.7742	10	0.87932	D	0	-21.8308	17.8355	0.88694	0.0:1.0:0.0:0.0	.	89	Q9H175	CSRN2_HUMAN	R	89	ENSP00000228515:G89R;ENSP00000447657:G89R	ENSP00000228515:G89R	G	-	1	0	CSRNP2	49754019	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	7.565000	0.82337	2.826000	0.97356	0.655000	0.94253	GGT	CSRNP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000404893.1	-1.234227	KEEP		-	22.885942	0.070866	9	118	---	---	---	---	1	0.9715539	7	75	0	112	10	129	0	112	2	0	0	0	0	0	112	10	129	0	112	2	TP
IGHG3	0	broad.mit.edu	37	14	106237582	106237582	+	RNA	SNP	C	C	T	rs2983776		THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr14:106237582C>T	ENST00000390551.2	-	0	160										NA		NA									NA						GTAGGACAGCCGGGAAGGTGT	0.637		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA				NA		44	41	42	NA		NA	NA	14	NA	NA											NA				106237582		1903	4068	5971										NA		ENST00000390551.2	37																																																																																				IGHG3-001	KNOWN	mRNA_start_NF|cds_start_NF|basic	IG_C_gene	NA	IG_C_gene	OTTHUMT00000326654.1	-3.520878	KEEP		-	7.332445	0.056604	3	50	---	---	---	---	1	1	39	7881	0	51	3	51	0	51	2	0	0	0	0	0	51	3	51	0	51	2	TP
Unknown	0	broad.mit.edu	37	14	107062535	107062535	+	IGR	SNP	C	C	G			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr14:107062535C>G			NA	NA				IGHV3-53 (13194 upstream) : IGHV1-58 (15837 downstream)						NA		NA									NA						CTGCCACCAGCAGGAGGAAGA	0.512		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA				NA		NA	NA	NA	NA		NA	NA	NA	NA	NA											NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			-5.932814	KEEP			8.073237	0.046875	3	61	---	---	---	---	1	0.7405265	176	1512	1	50	4	68	1	50	87	0	0	0	0	1	50	4	68	1	50	2	TP
PRSS27	83886	broad.mit.edu	37	16	2764076	2764076	+	Silent	SNP	G	G	A			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr16:2764076G>A	ENST00000302641.3	-	4	552	c.498C>T	c.(496-498)ccC>ccT	p.P166P	AC092117.1_ENST00000410123.1_RNA	NM_031948.3	NP_114154.1	Q9BQR3	PRS27_HUMAN	protease, serine 27	166	Peptidase S1.	NA			proteolysis	extracellular region	serine-type endopeptidase activity			breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(1)|lung(2)|ovary(1)	8						CTTCCTCACTGGGGCTGCCCC	0.597		NA						NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA				NA		88	89	89	NA		NA	NA	16	NA	NA											NA				2764076		2198	4300	6498	SO:0001819	synonymous_variant			ENSG00000172382	HGNC:15475	NM_031948	Approved	uc002crf.3	NA		ENST00000302641.3	37	CCDS10476.1																																																																																			PRSS27-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250908.1	197.377607	KEEP		-	200.234129	0.371134	72	122	A	PoN.13Oct2012	Reference	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	1	0.2899219	2	1	0	223	85	154	0	223	2	0	0	0	0	0	223	85	154	0	223	2	TP
NF1	4763	broad.mit.edu	37	17	29701105	29701105	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr17:29701105G>A	ENST00000358273.4	+	58	8835	c.8452G>A	c.(8452-8454)Gca>Aca	p.A2818T	NF1_ENST00000444181.2_Missense_Mutation_p.A611T|NF1_ENST00000356175.3_Missense_Mutation_p.A2797T	NM_001042492.2	NP_001035957.1	P21359	NF1_HUMAN	neurofibromin 1	2818		NA			actin cytoskeleton organization|adrenal gland development|artery morphogenesis|camera-type eye morphogenesis|cerebral cortex development|collagen fibril organization|forebrain astrocyte development|forebrain morphogenesis|heart development|liver development|MAPKKK cascade|metanephros development|myelination in peripheral nervous system|negative regulation of cell migration|negative regulation of endothelial cell proliferation|negative regulation of MAP kinase activity|negative regulation of MAPKKK cascade|negative regulation of neuroblast proliferation|negative regulation of oligodendrocyte differentiation|negative regulation of transcription factor import into nucleus|osteoblast differentiation|phosphatidylinositol 3-kinase cascade|pigmentation|positive regulation of adenylate cyclase activity|positive regulation of neuron apoptosis|Ras protein signal transduction|regulation of blood vessel endothelial cell migration|regulation of bone resorption|response to hypoxia|smooth muscle tissue development|spinal cord development|sympathetic nervous system development|visual learning|wound healing	axon|cytoplasm|dendrite|intrinsic to internal side of plasma membrane|nucleus	protein binding|Ras GTPase activator activity	p.0?(8)|p.?(3)	NF1/ACCN1(2)	autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9)	599		all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659)		UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146)		CCACGGATCCGCAAGCCAAGT	0.458		NA	"""D, Mis, N, F, S, O"""		"""neurofibroma, glioma"""	"""neurofibroma, glioma"""		NA	Neurofibromatosis, type 1	TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		yes	Rec	yes	Neurofibromatosis type 1	17	17q12	4763	neurofibromatosis type 1 gene		O	11	Whole gene deletion(8)|Unknown(3)	soft_tissue(7)|autonomic_ganglia(2)|lung(1)|central_nervous_system(1)	NA	NA	NA	NA	NA				NA		78	75	76	NA		NA	NA	17	NA	NA											NA				29701105		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	NF1, von Recklinghausen disease, incl.: Hereditary Spinal Neurofibromatosis, Neurofibromatosis-Noonan syndrome	ENSG00000196712	HGNC:7765	NM_000267	Approved	uc002hgg.3	NA	O00662|Q14284|Q14930|Q9UMK3	ENST00000358273.4	37	CCDS42292.1	.	.	.	.	.	.	.	.	.	.	G	27.7	4.858528	0.91433	.	.	ENSG00000196712	ENST00000358273;ENST00000356175;ENST00000456735;ENST00000444181	T;T;T;T	0.59502	2.83;2.98;2.66;0.26	5.63	5.63	0.86233	.	0.000000	0.85682	D	0.000000	T	0.67107	0.2858	L	0.29908	0.895	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.76575	0.988;0.972	T	0.63497	-0.6624	9	.	.	.	.	19.6809	0.95962	0.0:0.0:1.0:0.0	.	2797;2818	P21359-2;P21359	.;NF1_HUMAN	T	2818;2797;2481;611	ENSP00000351015:A2818T;ENSP00000348498:A2797T;ENSP00000389907:A2481T;ENSP00000396481:A611T	.	A	+	1	0	NF1	26725231	1.000000	0.71417	1.000000	0.80357	1.000000	0.99986	9.369000	0.97156	2.644000	0.89710	0.655000	0.94253	GCA	NF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256351.2	-4.852337	KEEP		+	8.732126	0.059701	4	63	---	---	---	---	0	0.9520626	0	115	0	76	4	78	0	76	2	1	0.9999912	4	1089	0	76	4	78	0	76	2	TP
SRSF2	6427	broad.mit.edu	37	17	74732250	74732250	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-IM-A3EB-Tumor-SM-2HRMK	THCA-TCGA-IM-A3EB-Normal-SM-2HRMP	g.chr17:74732250G>C	ENST00000392485.2	-	2	831	c.659C>G	c.(658-660)tCc>tGc	p.S220C	MFSD11_ENST00000593181.1_5'Flank|MFSD11_ENST00000591864.1_5'Flank|SRSF2_ENST00000508921.3_Missense_Mutation_p.S208C|MFSD11_ENST00000590514.1_5'Flank|MFSD11_ENST00000590393.1_5'Flank|SRSF2_ENST00000359995.5_Missense_Mutation_p.S220C|MFSD11_ENST00000355954.3_5'Flank|MFSD11_ENST00000588460.1_5'Flank|MIR636_ENST00000384825.1_RNA|MFSD11_ENST00000336509.4_5'Flank|RP11-318A15.7_ENST00000587459.1_Intron|MFSD11_ENST00000586622.1_Intron	NM_003016.4	NP_003007.2	Q01130	SRSF2_HUMAN	serine/arginine-rich splicing factor 2	220	Arg/Ser-rich (RS domain).	NA			mRNA 3'-end processing|mRNA export from nucleus|nuclear mRNA splicing, via spliceosome|termination of RNA polymerase II transcription	nuclear speck	nucleotide binding|protein binding|RNA binding|transcription corepressor activity			haematopoietic_and_lymphoid_tissue(320)|kidney(2)|large_intestine(1)|lung(4)|prostate(2)	329						TTCTTAAGAGGACACCGCTCC	0.483		NA	Mis		"""MDS, CLL"""			NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA			Dom	yes		17	17q25	6427	serine/arginine-rich splicing factor 2		L	0			NA	NA	NA	NA	NA				NA		72	79	76	NA		NA	NA	17	NA	NA											NA				74732250		2203	4300	6503	SO:0001583	missense			ENSG00000161547	HGNC:10783	NM_003016	Approved	uc002jsv.3	NA	B3KWD5	ENST00000392485.2	37	CCDS11749.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	15.81|15.81	2.943346|2.943346	0.53079|0.53079	.|.	.|.	ENSG00000161547|ENSG00000161547	ENST00000452355|ENST00000392485;ENST00000358156;ENST00000359995	.|T;T	.|0.40225	.|1.2;1.04	4.85|4.85	4.85|4.85	0.62838|0.62838	.|.	.|0.377447	.|0.22819	.|N	.|0.055250	T|T	0.27134|0.27134	0.0665|0.0665	N|N	0.03608|0.03608	-0.345|-0.345	0.80722|0.80722	D|D	1|1	.|D;D	.|0.58620	.|0.983;0.983	.|B;B	.|0.43783	.|0.431;0.431	T|T	0.43845|0.43845	-0.9366|-0.9366	6|10	0.87932|0.87932	D|D	0|0	.|.	17.9573|17.9573	0.89073|0.89073	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	.|208;220	.|B4DN89;Q01130	.|.;SRSF2_HUMAN	A|C	170|220;208;200	.|ENSP00000376276:S220C;ENSP00000353089:S200C	ENSP00000391278:P170A|ENSP00000350877:S208C	P|S	-|-	1|2	0|0	SRSF2|SRSF2	72243845|72243845	1.000000|1.000000	0.71417|0.71417	0.986000|0.986000	0.45419|0.45419	0.932000|0.932000	0.56968|0.56968	7.517000|7.517000	0.81783|0.81783	2.227000|2.227000	0.72691|0.72691	0.655000|0.655000	0.94253|0.94253	CCT|TCC	SRSF2-003	KNOWN	alternative_3_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000437489.1	-31.217783	KEEP		-	7.255354	0.020134	3	146	---	---	---	---	1	0.98115	11	448	0	144	3	160	0	144	2	0	0	0	0	0	144	3	160	0	144	2	TP
